ECZEMA
Clinical trials for ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ECZEMA trials appear
Sign up with your email to follow new studies for ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Extended trial tests eczema Drug's staying power in kids
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effectiveness of the drug lebrikizumab for children and teenagers with moderate-to-severe eczema. It is an extension study for about 310 participants who completed a previous trial, following them for up to 116 weeks. The ma…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial aims to tame severe childhood eczema
Disease control OngoingThis study is testing an investigational drug called lebrikizumab in children and teenagers with moderate-to-severe eczema. Participants are randomly assigned to receive either the drug or a placebo to see if it improves their skin condition and reduces itching. The main goals ar…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Baby skin cream trial aims to stop allergies before they start
Prevention OngoingThis study tests whether using special skin barrier creams and a steroid cream regularly (proactive care) in babies who already have eczema can prevent them from developing food allergies. It compares this approach to only treating eczema when it flares up (reactive care). The go…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC